Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 12
Original Research
A Cost per Responder Model for Abatacept versus Adalimumab Among Rheumatoid Arthritis Patients with Seropositivity
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,069 | Dovepress* | 4,729+ | 890 | 5,619 | |
| PubMed Central* | 340 | 110 | 450 | ||
| Totals | 5,069 | 1,000 | 6,069 | ||
| *Since 15 October 2020 | |||||
View citations on PubMed Central and Google Scholar